Vol 7: Accrual to a randomised trial of adjuvant whole brain radiotherapy for treatment of melanoma brain metastases is feasible.Reportar como inadecuado



 Vol 7: Accrual to a randomised trial of adjuvant whole brain radiotherapy for treatment of melanoma brain metastases is feasible.


Vol 7: Accrual to a randomised trial of adjuvant whole brain radiotherapy for treatment of melanoma brain metastases is feasible. - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Descargar gratis o leer online en formato PDF el libro: Vol 7: Accrual to a randomised trial of adjuvant whole brain radiotherapy for treatment of melanoma brain metastases is feasible.
This article is from BMC Research Notes, volume 7.AbstractBackground: Brain metastases (BMs) are common in melanoma patients. Adjuvant whole brain radiotherapy (WBRT) following local treatment of intracranial melanoma metastases with neurosurgery and-or stereotactic radiosurgery is controversial. A randomised trial is needed. However, accrual to WB

Autor: Fogarty, Gerald B; Hong, Angela; Jacobsen, Kari Dolven; Reisse, Claudius H; Shivalingam, Brindha; Burmeister, Bryan; Haydu, Lauren E; Paton, Elizabeth

Fuente: https://archive.org/







Documentos relacionados